| Symbol |
Name |
|
ACE
|
angiotensin I converting enzyme
|
|
ACR
|
acrosin
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AIRE
|
autoimmune regulator
|
|
ALB
|
albumin
|
|
AQP5
|
aquaporin 5
|
|
AQP8
|
aquaporin 8
|
|
AQP9
|
aquaporin 9
|
|
ARR3
|
arrestin 3, retinal (X-arrestin)
|
|
ATF7IP
|
activating transcription factor 7 interacting protein
|
|
B2M
|
beta-2-microglobulin
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCR
|
breakpoint cluster region
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP6
|
bone morphogenetic protein 6
|
|
CASR
|
calcium-sensing receptor
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CFB
|
complement factor B
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTSS
|
cathepsin S
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DGKQ
|
diacylglycerol kinase, theta 110kDa
|
|
DYM
|
dymeclin
|
|
E2F1
|
E2F transcription factor 1
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCRL4
|
Fc receptor-like 4
|
|
FLVCR1
|
feline leukemia virus subgroup C cellular receptor 1
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
GDF6
|
growth differentiation factor 6
|
|
GLO1
|
glyoxalase I
|
|
GTF2I
|
general transcription factor IIi
|
|
HBA1
|
hemoglobin, alpha 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HBG1
|
hemoglobin, gamma A
|
|
HBG2
|
hemoglobin, gamma G
|
|
HMOX1
|
heme oxygenase 1
|
|
HPSE
|
heparanase
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL7
|
interleukin 7
|
|
IRAK1BP1
|
interleukin-1 receptor-associated kinase 1 binding protein 1
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITSN2
|
intersectin 2
|
|
LBR
|
lamin B receptor
|
|
LYZ
|
lysozyme
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
PC
|
pyruvate carboxylase
|
|
PHIP
|
pleckstrin homology domain interacting protein
|
|
PLS3
|
plastin 3
|
|
PMCH
|
pro-melanin-concentrating hormone
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha
|
|
PTN
|
pleiotrophin
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
PUF60
|
poly-U binding splicing factor 60KDa
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RORC
|
RAR-related orphan receptor C
|
|
SELE
|
selectin E
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SPG7
|
spastic paraplegia 7 (pure and complicated autosomal recessive)
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
TACR1
|
tachykinin receptor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
TLR3
|
toll-like receptor 3
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TP53
|
tumor protein p53
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRIM13
|
tripartite motif containing 13
|
|
TSPYL2
|
TSPY-like 2
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VTCN1
|
V-set domain containing T cell activation inhibitor 1
|
